Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). - Wikidata - wikimedia - TriplyDB

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

http://www.wikidata.org/entity/Q36746989

about

Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics Endometrial cancer and Lynch syndrome: clinical and pathologic considerations Risks of Lynch syndrome cancers for MSH6 mutation carriers.Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery Improving identification of lynch syndrome patients: a comparison of research data with clinical records.Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management.Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.Racial differences in MLH1 and MSH2 mutation: an analysis of yellow race and white race based on the InSiGHT database.Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation Lower gastrointestinal tract cancer predisposition syndromes A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome.Application of molecular diagnostics for the detection of Lynch syndrome.Efficacy of an educational intervention on family physicians' risk assessment and management of colorectal cancer.Breast cancer susceptibility: current knowledge and implications for genetic counselling Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case.EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer How can polygenic inheritance be used in population screening for common diseases?Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress.MUTYH Associated Polyposis (MAP).Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome.Identification of patients at risk for hereditary colorectal cancer Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.Cervical neuroendocrine tumor in a young female with Lynch Syndrome.Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: report of a case.CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore.Screening for colorectal cancer: possible improvements by risk assessment evaluation?

P2860

Q24649491-24ECC389-2C33-417C-878D-88055884D958 Q24655053-D33BE17E-D6FF-4F47-9C8B-E23DBAF86BA7 Q28253670-9589A60B-19F6-43A9-9421-194D648573A2 Q28303873-C8C0F3E8-416F-440E-8C95-ED19DA150DC6 Q30492977-52E25BBC-25B1-4A50-A074-B6BB8B96CB71 Q30558412-326F2EF0-48DA-4D5F-AA43-E8A3F028727A Q30580847-F4CA4BA0-A54A-4F47-9537-031F30347DFA Q33422607-61CD98E9-A7BF-4D2F-B47E-C0661F61416A Q33522197-79752E77-41DD-4A1F-B963-7C6AF935F669 Q33582756-47EC042B-1874-4BFF-AFDE-5128E8EC9C0F Q33658603-4D4EA247-D350-483F-9B18-B3712F604B34 Q33715019-CA4D43BB-4AF3-4E44-8A5C-57959883E445 Q33770899-CA252A26-BE82-42E9-B3AF-597FE9F91ED6 Q33807931-8B29E6B4-50C3-410A-9853-18E573E75D76 Q33829127-D5092B08-FD8D-4466-A761-F3D4985F1A1B Q33920573-6C571466-3894-4C24-9267-DE8EAF0E6B53 Q34081661-853E2F71-FFB0-43E9-8469-121120BE138F Q34088809-CFE41B8A-DE24-464D-AFCB-2BA3D1BDC129 Q34156897-60341698-C48E-4440-A693-5C0AA313689D Q34161642-CA6D3301-70E0-40A8-96F0-EF38ED5BA0D5 Q34174590-AC22197D-3DE2-4BE8-A7D4-3E222176AE70 Q34239731-3CAB2C57-ECFA-40A4-805D-392BE72621E5 Q34243496-F32668C0-C070-4978-8014-AF450391CB76 Q34289520-09DF0304-DFC8-4C95-928F-4C01DBAB60AA Q34296467-6D7CAFD4-698F-492A-A10C-DFB1FCBD73C9 Q34327946-950FF3E1-9653-4E97-87D7-DE0F52F5D1F4 Q34346668-21BCE2E8-201B-429F-B5AC-3D0F5356323F Q34442883-BC952421-D474-4A49-B209-8173C42E60F3 Q34565199-078CC59B-E8B4-48FA-ADC6-C42130F4D067 Q34608633-159CDC75-10BA-4373-BB67-AD5ADC39B57F Q34648373-E7DF6B90-E0E5-4EF8-9279-BE10AD8493F4 Q34652530-E995413F-9475-4A11-8BF6-1B97AC96173D Q34950524-AB1BEA04-DCFA-46E4-B0E5-F8311D5D89F3 Q34966336-A5C528E4-4509-482F-86DF-2680AFA46F2F Q35019094-1CAD0DE3-3DDA-4752-8B3E-3955AF53F9FB Q35054808-8D305741-7AA4-4ECF-86A9-00B999EE2DB9 Q35087269-FFA2FD72-EF08-45D8-ABB2-68589DA45E4B Q35110064-DC932D28-7FEF-44FB-87EA-3D1551752441 Q35141950-84DAA3A2-86D1-4A33-919D-E9519A7A6FF9 Q35496548-94960980-C97A-48F0-959C-E225C68BBAF4

P2860

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

http://www.wikidata.org/entity/Q36746989

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Guidelines for the clinical ma ...... editary non-polyposis cancer).

@en

type

label

Guidelines for the clinical ma ...... editary non-polyposis cancer).

@en

prefLabel

Guidelines for the clinical ma ...... editary non-polyposis cancer).

@en

P1433

Q36746989-ED41BA9C-1D1C-44EA-9492-0B192A8966F2

P1476

Q36746989-289CF3A4-9152-47BE-911B-A2845635BF1E

P2093

Q36746989-03799886-08B2-42B5-8E44-B57929E30287

Q36746989-2658C91B-692C-49C3-A7C2-53AE35162D30

Q36746989-28D794F9-55F8-4ED0-AEBA-E03A0F35EB72

Q36746989-3BEEA7F8-8613-4A81-946B-EE3DDCE4450A

Q36746989-44975CFC-61F0-44B7-BC20-B34E3A0FA34F

Q36746989-6A6B8F66-A105-483C-BCC0-E886E43C99EF

Q36746989-6B8616AC-94C0-4331-8671-803231DAD634

Q36746989-708D1BEC-6FCF-48E6-8151-41C76DE4D33B

Q36746989-7927C08F-643D-4055-8F8B-D9C7C3117E69

Q36746989-D8B8708B-B56A-493D-9425-5B97BFA8CAA7

P2860

Q36746989-0AD483C6-A698-4CC2-B3B4-7F76FEC53E47

Q36746989-0B654ECF-1D66-4E4E-9AF9-DAC0CE4A784F

Q36746989-0D9075F2-A58F-43C5-A259-820F8E5F3E6D

Q36746989-2833FAAA-7C68-4F46-BB39-532F9564024D

Q36746989-2A183272-6BA0-4E72-9FD7-F01FAD9A4094

Q36746989-38017622-9EE5-4BB4-8326-42866362C3FC

Q36746989-3BD65045-0AE7-4547-9FC5-E8D7D993C1C8

Q36746989-3FE3005D-82C0-49AE-864D-95461574D678

Q36746989-40EF4479-4E9B-4184-9C0C-8203A1AAB880

Q36746989-53E34A7F-64BC-45BC-90E8-E22412A079E9

P304

Q36746989-6AD2ADD2-B1FF-46A8-92FD-E4C468F237B3

P31

Q36746989-178882C8-A57D-456F-971F-F997F834BACE

P356

Q36746989-99E40F7A-170B-4C5A-B9CE-1A5F7D61EC4A

P407

Q36746989-90033AAE-886C-40E7-95FE-6B3A5C355799

P433

Q36746989-84F63BE7-1BCD-4FA9-9013-7D8828701577

P478

Q36746989-6519925C-BCE8-447F-B08E-E0BAEBC4BFD2

P50

Q36746989-0632AAF6-D3FC-4029-AE60-F82701443789

Q36746989-210D87D2-B280-4A75-82D7-7920E6A7B115

Q36746989-3320CBDD-AEC2-4C52-BDFF-A19F09F9EAB1

Q36746989-37F644F3-05C2-4F1E-A098-3F791EBDF0F6

Q36746989-4FA7C94C-A17C-4BD3-8EF1-A70809046631

Q36746989-6982C7AC-6B52-4B50-8459-4C454072944F

Q36746989-82E4A696-0CBE-4CA9-BB4E-F7D204E363C8

Q36746989-D2995F9E-7B23-44A2-8E5F-6356D823A1BF

P577

Q36746989-7B147644-7E40-4AAF-9AA7-B4B0FF1EE1FF

P5875

Q36746989-A2314C64-0DDF-4DA3-807A-D1F460D72780

P698

Q36746989-5EF5A66B-2BBA-4D7A-B8A3-CB7ED43B8012

P932

Q36746989-5D26BA7E-94E1-445B-90FB-652435D21A54

P356

JMG.2007.048991

P1433

Journal of Medical Genetics

P1476

Guidelines for the clinical ma ...... reditary non-polyposis cancer)

@en

P2093

A Alonso

http://www.w3.org/2001/XMLSchema#string

A Stormorken

http://www.w3.org/2001/XMLSchema#string

F J Hes

http://www.w3.org/2001/XMLSchema#string

F Nagengast

http://www.w3.org/2001/XMLSchema#string

G Möslein

http://www.w3.org/2001/XMLSchema#string

J R Sampson

http://www.w3.org/2001/XMLSchema#string

J Wijnen

http://www.w3.org/2001/XMLSchema#string

J-P Mecklin

http://www.w3.org/2001/XMLSchema#string

L Renkonen-Sinisalo

http://www.w3.org/2001/XMLSchema#string

P Møller

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

P304

353-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMG.2007.048991

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Gabriel Capella

Christoph Engel

P577

2007-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6479818

http://www.w3.org/2001/XMLSchema#string

P698

17327285

http://www.w3.org/2001/XMLSchema#string

P932

2740877

http://www.w3.org/2001/XMLSchema#string